Quarterly report pursuant to Section 13 or 15(d)

EARNINGS (LOSS) PER SHARE (Tables)

v3.24.2.u1
EARNINGS (LOSS) PER SHARE (Tables)
6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share
The reconciliations of the net loss and the weighted average number of shares used in the computations of basic and diluted loss per share are as follows:
Three Months Ended June 30, Six Months Ended June 30,
2024 2023 2024 2023
Numerator:
Net loss and comprehensive loss
$ (1,938) $ (14,036) $ (20,293) $ (26,476)
Net loss and comprehensive loss - diluted
$ (1,938) $ (14,036) $ (20,293) $ (26,476)
Denominator:
Weighted-average shares of common stock - basic 195,138,473  194,756,391  195,135,057  194,405,562 
Weighted-average shares of common stock - diluted 195,138,473  194,756,391  195,135,057  194,405,562 
Loss per common share:
Basic $ (0.01) $ (0.07) $ (0.10) $ (0.14)
Diluted $ (0.01) $ (0.07) $ (0.10) $ (0.14)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table summarizes weighted average instruments that may, in the future, have a dilutive effect on earnings (loss) per share, but were excluded from consideration in the computation of diluted net loss per share for the three and six months ended June 30, 2024 and 2023, because the impact of including them would have been anti-dilutive:
Three Months Ended June 30, Six Months Ended June 30,
2024 2023 2024 2023
Stock options 28,027,491  29,248,553  27,840,551  28,941,749 
Warrants (derivative liabilities and equity) 88,564,891  86,097,189  88,237,693  86,043,865 
Unvested restricted stock awards 1,861  376,980  1,861  746,843 
116,594,243  115,722,722  116,080,105  115,732,457